Qulipta 60 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26F9H08
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,320
Award facts
- Contract value 100% obligated
- $5,319.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,319.71 to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count supply) on November 20, 2025, with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, leveraging its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a prime vendor for federal medical procurement supporting military healthcare systems and other government agencies. The company's federal contract portfolio demonstrates extensive experience supplying a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Qulipta, an antipsychotic medication used in treating mental health conditions, exemplifies the company's role in ensuring the continuous supply of critical medications to support Defense Health Agency operations and other federal healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F9H08?
SPE2DR26F9H08 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F9H08 worth?
The government has obligated $5,320 on SPE2DR26F9H08.
Is contract SPE2DR26F9H08 an order under another contract?
Yes. SPE2DR26F9H08 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9H08 competed?
The extent of competition for SPE2DR26F9H08 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award